Bioqual (Bioqual) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Bioqual's net issuance of preferred for the six months ended in May. 2018 was $0.00 Mil. The number is 0, which means that Bioqual has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Bioqual's net issuance of preferred for the trailing twelve months (TTM) ended in May. 2018 was $0.00 Mil.

Bioqual Net Issuance of Preferred Stock Historical Data

The historical data trend for Bioqual's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Net Issuance of Preferred Stock Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
Net Issuance of Preferred Stock	Get a 7-Day Free Trial										-	-	-	-	-

Bioqual Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in May. 2018 was $0.00 Mil.

Bioqual Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Bioqual's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines